Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]

 CASP3_HUMAN             Reviewed;         277 AA.
P42574; A8K5M2; D3DP53; Q96AN1; Q96KP2;
01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
11-OCT-2005, sequence version 2.
22-NOV-2017, entry version 208.
RecName: Full=Caspase-3;
Short=CASP-3;
EC=3.4.22.56;
AltName: Full=Apopain;
AltName: Full=Cysteine protease CPP32;
Short=CPP-32;
AltName: Full=Protein Yama;
AltName: Full=SREBP cleavage activity 1;
Short=SCA-1;
Contains:
RecName: Full=Caspase-3 subunit p17;
Contains:
RecName: Full=Caspase-3 subunit p12;
Flags: Precursor;
Name=CASP3; Synonyms=CPP32;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
TISSUE=T-cell;
PubMed=7983002;
Fernandes-Alnemri T., Litwack G., Alnemri E.S.;
"CPP32, a novel human apoptotic protein with homology to
Caenorhabditis elegans cell death protein Ced-3 and mammalian
interleukin-1 beta-converting enzyme.";
J. Biol. Chem. 269:30761-30764(1994).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=7774019; DOI=10.1016/0092-8674(95)90541-3;
Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z.,
Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M.;
"Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable
protease that cleaves the death substrate poly(ADP-ribose)
polymerase.";
Cell 81:801-809(1995).
[3]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ASP-190.
PubMed=15003516; DOI=10.1016/j.bbrc.2004.02.021;
Pelletier M., Cartron P.F., Delaval F., Meflah K., Vallette F.M.,
Oliver L.;
"Caspase 3 activation is controlled by a sequence located in the N-
terminus of its large subunit.";
Biochem. Biophys. Res. Commun. 316:93-99(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Tongue;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
NIEHS SNPs program;
Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lymph;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
PROTEIN SEQUENCE OF 29-46 AND 176-193, FUNCTION, AND VARIANT ASP-190.
PubMed=7596430; DOI=10.1038/376037a0;
Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K.,
Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A.,
Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Li V.L.,
Miller D.K.;
"Identification and inhibition of the ICE/CED-3 protease necessary for
mammalian apoptosis.";
Nature 376:37-43(1995).
[9]
PROTEOLYTIC PROCESSING.
PubMed=8755496; DOI=10.1073/pnas.93.15.7464;
Fernandes-Alnemri T., Armstrong R.C., Krebs J.F., Srinivasula S.M.,
Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J.,
Litwack G., Alnemri E.S.;
"In vitro activation of CPP32 and Mch3 by Mch4, a novel human
apoptotic cysteine protease containing two FADD-like domains.";
Proc. Natl. Acad. Sci. U.S.A. 93:7464-7469(1996).
[10]
CLEAVAGE OF HUNTINGTIN.
PubMed=8696339; DOI=10.1038/ng0896-442;
Goldberg Y.P., Nicholson D.W., Rasper D.M., Kalchman M.A., Koide H.B.,
Graham R.K., Bromm M., Kazemi-Esfarjani P., Thornberry N.A.,
Vaillancourt J.P., Hayden M.R.;
"Cleavage of huntingtin by apopain, a proapoptotic cysteine protease,
is modulated by the polyglutamine tract.";
Nat. Genet. 13:442-449(1996).
[11]
S-NITROSYLATION AT CYS-163.
PubMed=10213689; DOI=10.1126/science.284.5414.651;
Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X.,
Kane L.S., Gow A.J., Stamler J.S.;
"Fas-induced caspase denitrosylation.";
Science 284:651-654(1999).
[12]
INTERACTION WITH BIRC6/BRUCE.
PubMed=15200957; DOI=10.1016/j.molcel.2004.05.018;
Bartke T., Pohl C., Pyrowolakis G., Jentsch S.;
"Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3
ubiquitin ligase.";
Mol. Cell 14:801-811(2004).
[13]
ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[14]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[15]
FUNCTION IN CELL ADHESION.
PubMed=21357690; DOI=10.1074/jbc.M110.195461;
Cabrera J.R., Bouzas-Rodriguez J., Tauszig-Delamasure S., Mehlen P.;
"RET modulates cell adhesion via its cleavage by caspase in
sympathetic neurons.";
J. Biol. Chem. 286:14628-14638(2011).
[16]
ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=22223895; DOI=10.1074/mcp.M111.015131;
Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
Meinnel T., Giglione C.;
"Comparative large-scale characterisation of plant vs. mammal proteins
reveals similar and idiosyncratic N-alpha acetylation features.";
Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
[17]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[18]
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 28-277.
PubMed=8673606; DOI=10.1038/nsb0796-619;
Rotonda J., Nicholson D.W., Fazil K.M., Gallant M., Gareau Y.,
Labelle M., Peterson E.P., Rasper D.M., Ruel R., Vaillancourt J.P.,
Thornberry N.A., Becker J.W.;
"The three-dimensional structure of apopain/CPP32, a key mediator of
apoptosis.";
Nat. Struct. Biol. 3:619-625(1996).
[19]
X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 35-173 AND 185-277.
PubMed=9045680; DOI=10.1074/jbc.272.10.6539;
Mittl P.R.E., di Marco S., Krebs J.F., Bai X., Karanewsky D.S.,
Priestle J.P., Tomaselli K.J., Gruetter M.G.;
"Structure of recombinant human CPP32 in complex with the tetrapeptide
acetyl-Asp-Val-Ala-Asp fluoromethyl ketone.";
J. Biol. Chem. 272:6539-6547(1997).
[20]
X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
PubMed=10821855; DOI=10.1074/jbc.275.21.16007;
Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A.,
Kikly K., Winkler J.D., Sung C.-M., Debouck C., Richardson S.,
Levy M.A., DeWolf W.E. Jr., Keller P.M., Tomaszek T., Head M.S.,
Ryan M.D., Haltiwanger R.C., Liang P.-H., Janson C.A., McDevitt P.J.,
Johanson K., Concha N.O., Chan W., Abdel-Meguid S.S., Badger A.M.,
Lark M.W., Nadeau D.P., Suva L.J., Gowen M., Nuttall M.E.;
"Potent and selective nonpeptide inhibitors of caspases 3 and 7
inhibit apoptosis and maintain cell functionality.";
J. Biol. Chem. 275:16007-16014(2000).
-!- FUNCTION: Involved in the activation cascade of caspases
responsible for apoptosis execution. At the onset of apoptosis it
proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a
'216-Asp-|-Gly-217' bond. Cleaves and activates sterol regulatory
element binding proteins (SREBPs) between the basic helix-loop-
helix leucine zipper domain and the membrane attachment domain.
Cleaves and activates caspase-6, -7 and -9. Involved in the
cleavage of huntingtin. Triggers cell adhesion in sympathetic
neurons through RET cleavage. {ECO:0000269|PubMed:21357690,
ECO:0000269|PubMed:7596430}.
-!- CATALYTIC ACTIVITY: Strict requirement for an Asp residue at
positions P1 and P4. It has a preferred cleavage sequence of Asp-
Xaa-Xaa-Asp-|- with a hydrophobic amino-acid residue at P2 and a
hydrophilic amino-acid residue at P3, although Val or Ala are also
accepted at this position.
-!- ENZYME REGULATION: Inhibited by isatin sulfonamides.
-!- SUBUNIT: Heterotetramer that consists of two anti-parallel
arranged heterodimers, each one formed by a 17 kDa (p17) and a 12
kDa (p12) subunit. Interacts with BIRC6/bruce.
{ECO:0000269|PubMed:15200957}.
-!- INTERACTION:
O43823:AKAP8; NbExp=5; IntAct=EBI-524064, EBI-1237481;
Q9Y243:AKT3; NbExp=2; IntAct=EBI-524064, EBI-296115;
P55212:CASP6; NbExp=2; IntAct=EBI-524064, EBI-718729;
P55211:CASP9; NbExp=2; IntAct=EBI-524064, EBI-516799;
Q00987:MDM2; NbExp=2; IntAct=EBI-524064, EBI-389668;
P09874:PARP1; NbExp=2; IntAct=EBI-524064, EBI-355676;
P10599:TXN; NbExp=6; IntAct=EBI-524064, EBI-594644;
Q9BYP7:WNK3; NbExp=2; IntAct=EBI-524064, EBI-1182602;
P98170:XIAP; NbExp=3; IntAct=EBI-524064, EBI-517127;
-!- SUBCELLULAR LOCATION: Cytoplasm.
-!- TISSUE SPECIFICITY: Highly expressed in lung, spleen, heart, liver
and kidney. Moderate levels in brain and skeletal muscle, and low
in testis. Also found in many cell lines, highest expression in
cells of the immune system.
-!- PTM: Cleavage by granzyme B, caspase-6, caspase-8 and caspase-10
generates the two active subunits. Additional processing of the
propeptides is likely due to the autocatalytic activity of the
activated protease. Active heterodimers between the small subunit
of caspase-7 protease and the large subunit of caspase-3 also
occur and vice versa.
-!- PTM: S-nitrosylated on its catalytic site cysteine in unstimulated
human cell lines and denitrosylated upon activation of the Fas
apoptotic pathway, associated with an increase in intracellular
caspase activity. Fas therefore activates caspase-3 not only by
inducing the cleavage of the caspase zymogen to its active
subunits, but also by stimulating the denitrosylation of its
active site thiol. {ECO:0000269|PubMed:10213689}.
-!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/casp3/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; U13737; AAA65015.1; -; mRNA.
EMBL; U13738; AAB60355.1; -; mRNA.
EMBL; U26943; AAA74929.1; -; mRNA.
EMBL; AJ413269; CAC88866.1; -; mRNA.
EMBL; AK291337; BAF84026.1; -; mRNA.
EMBL; AY219866; AAO25654.1; -; Genomic_DNA.
EMBL; CH471056; EAX04673.1; -; Genomic_DNA.
EMBL; CH471056; EAX04674.1; -; Genomic_DNA.
EMBL; CH471056; EAX04675.1; -; Genomic_DNA.
EMBL; BC016926; AAH16926.1; -; mRNA.
CCDS; CCDS3836.1; -.
PIR; A55315; A55315.
RefSeq; NP_004337.2; NM_004346.3.
RefSeq; NP_116786.1; NM_032991.2.
RefSeq; XP_011530603.1; XM_011532301.1.
UniGene; Hs.141125; -.
PDB; 1CP3; X-ray; 2.30 A; A/B=1-277.
PDB; 1GFW; X-ray; 2.80 A; A=29-175, B=181-277.
PDB; 1I3O; X-ray; 2.70 A; A/C=1-175, B/D=176-277.
PDB; 1NME; X-ray; 1.60 A; A=29-174, B=186-277.
PDB; 1NMQ; X-ray; 2.40 A; A/B=29-277.
PDB; 1NMS; X-ray; 1.70 A; A/B=29-277.
PDB; 1PAU; X-ray; 2.50 A; A=29-175, B=176-277.
PDB; 1QX3; X-ray; 1.90 A; A=29-277.
PDB; 1RE1; X-ray; 2.50 A; A=29-175, B=176-277.
PDB; 1RHJ; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
PDB; 1RHK; X-ray; 2.50 A; A=29-175, B=176-277.
PDB; 1RHM; X-ray; 2.50 A; A/C=29-175, B/D=176-277.
PDB; 1RHQ; X-ray; 3.00 A; A/D=29-175, B/E=176-277.
PDB; 1RHR; X-ray; 3.00 A; A=29-175, B=176-277.
PDB; 1RHU; X-ray; 2.51 A; A=29-175, B=176-277.
PDB; 2C1E; X-ray; 1.77 A; A=29-175, B=176-277.
PDB; 2C2K; X-ray; 1.87 A; A=29-175, B=176-277.
PDB; 2C2M; X-ray; 1.94 A; A=29-175, B=176-277.
PDB; 2C2O; X-ray; 2.45 A; A=29-175, B=176-277.
PDB; 2CDR; X-ray; 1.70 A; A=29-175, B=176-277.
PDB; 2CJX; X-ray; 1.70 A; A=29-175, B=176-277.
PDB; 2CJY; X-ray; 1.67 A; A=29-175, B=176-277.
PDB; 2CNK; X-ray; 1.75 A; A=29-175, B=176-277.
PDB; 2CNL; X-ray; 1.67 A; A=29-175, B=176-277.
PDB; 2CNN; X-ray; 1.70 A; A=29-175, B=176-277.
PDB; 2CNO; X-ray; 1.95 A; A=29-175, B=176-277.
PDB; 2DKO; X-ray; 1.06 A; A=29-174, B=175-277.
PDB; 2H5I; X-ray; 1.69 A; A=29-174, B=184-277.
PDB; 2H5J; X-ray; 2.00 A; A/C=29-174, B/D=184-277.
PDB; 2H65; X-ray; 2.30 A; A/C=29-174, B/D=184-277.
PDB; 2J30; X-ray; 1.40 A; A=29-277.
PDB; 2J31; X-ray; 1.50 A; A=29-277.
PDB; 2J32; X-ray; 1.30 A; A=29-277.
PDB; 2J33; X-ray; 2.00 A; A=29-277.
PDB; 2XYG; X-ray; 1.54 A; A=29-174, B=185-277.
PDB; 2XYH; X-ray; 1.89 A; A=29-174, B=185-277.
PDB; 2XYP; X-ray; 1.86 A; A=29-174, B=185-277.
PDB; 2XZD; X-ray; 2.10 A; A/C=27-175, B/D=176-277.
PDB; 2XZT; X-ray; 2.70 A; A/C=29-175, B/D=176-277.
PDB; 2Y0B; X-ray; 2.10 A; A/C=29-175, B/D=176-277.
PDB; 3DEH; X-ray; 2.50 A; A/B/C/D=29-277.
PDB; 3DEI; X-ray; 2.80 A; A/B/C/D=29-277.
PDB; 3DEJ; X-ray; 2.60 A; A/B/C/D=29-277.
PDB; 3DEK; X-ray; 2.40 A; A/B/C/D=29-277.
PDB; 3EDQ; X-ray; 1.61 A; A/C=29-175, B/D=176-277.
PDB; 3GJQ; X-ray; 2.60 A; A/C=29-175, B/D=176-277.
PDB; 3GJR; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
PDB; 3GJS; X-ray; 1.90 A; A/C=29-175, B/D=176-277.
PDB; 3GJT; X-ray; 2.20 A; A/C=29-175, B/D=176-277.
PDB; 3H0E; X-ray; 2.00 A; A/B=29-277.
PDB; 3ITN; X-ray; 1.63 A; A=29-277.
PDB; 3KJF; X-ray; 2.00 A; A=29-175, B=176-277.
PDB; 3PCX; X-ray; 1.50 A; A=29-277.
PDB; 3PD0; X-ray; 2.00 A; A=29-277.
PDB; 3PD1; X-ray; 1.62 A; A=29-277.
PDB; 4DCJ; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
PDB; 4DCO; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
PDB; 4DCP; X-ray; 1.70 A; A/D=29-175, B/E=176-277.
PDB; 4EHA; X-ray; 1.70 A; A/C=1-277.
PDB; 4EHD; X-ray; 1.58 A; A=1-277.
PDB; 4EHF; X-ray; 1.66 A; A=1-277.
PDB; 4EHH; X-ray; 1.78 A; A=1-277.
PDB; 4EHK; X-ray; 1.67 A; A/C=1-277.
PDB; 4EHL; X-ray; 1.80 A; A/C=1-277.
PDB; 4EHN; X-ray; 1.69 A; A=1-277.
PDB; 4JJE; X-ray; 1.48 A; A=29-277.
PDB; 4JQY; X-ray; 2.50 A; A/B=34-277.
PDB; 4JQZ; X-ray; 2.89 A; A/B=34-277.
PDB; 4JR0; X-ray; 1.80 A; A/B=34-277.
PDB; 4PRY; X-ray; 1.70 A; A=1-277.
PDB; 4PS0; X-ray; 1.63 A; A/B=1-277.
PDB; 4QTX; X-ray; 1.97 A; A=1-277.
PDB; 4QTY; X-ray; 1.60 A; A=29-277.
PDB; 4QU0; X-ray; 1.95 A; A=1-277.
PDB; 4QU5; X-ray; 1.91 A; A=1-277.
PDB; 4QU8; X-ray; 1.72 A; A=1-277.
PDB; 4QU9; X-ray; 1.56 A; A=1-277.
PDB; 4QUA; X-ray; 1.89 A; A=1-277.
PDB; 4QUB; X-ray; 1.69 A; A=1-277.
PDB; 4QUD; X-ray; 2.00 A; A/B=1-277.
PDB; 4QUE; X-ray; 1.84 A; A/C=1-277.
PDB; 4QUG; X-ray; 1.92 A; A/C=1-277.
PDB; 4QUH; X-ray; 1.76 A; A/C=1-277.
PDB; 4QUI; X-ray; 1.76 A; A/B=1-277.
PDB; 4QUJ; X-ray; 1.50 A; A=1-277.
PDB; 4QUL; X-ray; 1.90 A; A/C=1-277.
PDB; 5I9B; X-ray; 1.80 A; A=1-277.
PDB; 5I9T; X-ray; 1.95 A; A/C=1-277.
PDB; 5IAB; X-ray; 1.79 A; A/C=1-277.
PDB; 5IAE; X-ray; 1.55 A; A/C=1-277.
PDB; 5IAG; X-ray; 1.98 A; A=1-277.
PDB; 5IAJ; X-ray; 1.58 A; A=1-277.
PDB; 5IAK; X-ray; 1.82 A; A=1-277.
PDB; 5IAN; X-ray; 2.70 A; A=1-277.
PDB; 5IAR; X-ray; 1.76 A; A=1-277.
PDB; 5IAS; X-ray; 1.54 A; A=1-277.
PDB; 5IBC; X-ray; 1.66 A; A=1-277.
PDB; 5IBP; X-ray; 1.38 A; A=1-277.
PDB; 5IBR; X-ray; 1.74 A; A/C=1-277.
PDB; 5IC4; X-ray; 2.65 A; A/C/E/G=1-175, B/D/F/H=176-276.
PDBsum; 1CP3; -.
PDBsum; 1GFW; -.
PDBsum; 1I3O; -.
PDBsum; 1NME; -.
PDBsum; 1NMQ; -.
PDBsum; 1NMS; -.
PDBsum; 1PAU; -.
PDBsum; 1QX3; -.
PDBsum; 1RE1; -.
PDBsum; 1RHJ; -.
PDBsum; 1RHK; -.
PDBsum; 1RHM; -.
PDBsum; 1RHQ; -.
PDBsum; 1RHR; -.
PDBsum; 1RHU; -.
PDBsum; 2C1E; -.
PDBsum; 2C2K; -.
PDBsum; 2C2M; -.
PDBsum; 2C2O; -.
PDBsum; 2CDR; -.
PDBsum; 2CJX; -.
PDBsum; 2CJY; -.
PDBsum; 2CNK; -.
PDBsum; 2CNL; -.
PDBsum; 2CNN; -.
PDBsum; 2CNO; -.
PDBsum; 2DKO; -.
PDBsum; 2H5I; -.
PDBsum; 2H5J; -.
PDBsum; 2H65; -.
PDBsum; 2J30; -.
PDBsum; 2J31; -.
PDBsum; 2J32; -.
PDBsum; 2J33; -.
PDBsum; 2XYG; -.
PDBsum; 2XYH; -.
PDBsum; 2XYP; -.
PDBsum; 2XZD; -.
PDBsum; 2XZT; -.
PDBsum; 2Y0B; -.
PDBsum; 3DEH; -.
PDBsum; 3DEI; -.
PDBsum; 3DEJ; -.
PDBsum; 3DEK; -.
PDBsum; 3EDQ; -.
PDBsum; 3GJQ; -.
PDBsum; 3GJR; -.
PDBsum; 3GJS; -.
PDBsum; 3GJT; -.
PDBsum; 3H0E; -.
PDBsum; 3ITN; -.
PDBsum; 3KJF; -.
PDBsum; 3PCX; -.
PDBsum; 3PD0; -.
PDBsum; 3PD1; -.
PDBsum; 4DCJ; -.
PDBsum; 4DCO; -.
PDBsum; 4DCP; -.
PDBsum; 4EHA; -.
PDBsum; 4EHD; -.
PDBsum; 4EHF; -.
PDBsum; 4EHH; -.
PDBsum; 4EHK; -.
PDBsum; 4EHL; -.
PDBsum; 4EHN; -.
PDBsum; 4JJE; -.
PDBsum; 4JQY; -.
PDBsum; 4JQZ; -.
PDBsum; 4JR0; -.
PDBsum; 4PRY; -.
PDBsum; 4PS0; -.
PDBsum; 4QTX; -.
PDBsum; 4QTY; -.
PDBsum; 4QU0; -.
PDBsum; 4QU5; -.
PDBsum; 4QU8; -.
PDBsum; 4QU9; -.
PDBsum; 4QUA; -.
PDBsum; 4QUB; -.
PDBsum; 4QUD; -.
PDBsum; 4QUE; -.
PDBsum; 4QUG; -.
PDBsum; 4QUH; -.
PDBsum; 4QUI; -.
PDBsum; 4QUJ; -.
PDBsum; 4QUL; -.
PDBsum; 5I9B; -.
PDBsum; 5I9T; -.
PDBsum; 5IAB; -.
PDBsum; 5IAE; -.
PDBsum; 5IAG; -.
PDBsum; 5IAJ; -.
PDBsum; 5IAK; -.
PDBsum; 5IAN; -.
PDBsum; 5IAR; -.
PDBsum; 5IAS; -.
PDBsum; 5IBC; -.
PDBsum; 5IBP; -.
PDBsum; 5IBR; -.
PDBsum; 5IC4; -.
ProteinModelPortal; P42574; -.
SMR; P42574; -.
BioGrid; 107286; 100.
DIP; DIP-268N; -.
ELM; P42574; -.
IntAct; P42574; 54.
MINT; MINT-147180; -.
STRING; 9606.ENSP00000311032; -.
BindingDB; P42574; -.
ChEMBL; CHEMBL2334; -.
DrugBank; DB06862; 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID.
DrugBank; DB08251; 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID.
DrugBank; DB03124; 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid.
DrugBank; DB08229; [N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID.
DrugBank; DB05408; IDN-6556.
DrugBank; DB07696; methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate.
DrugBank; DB01017; Minocycline.
GuidetoPHARMACOLOGY; 1619; -.
MEROPS; C14.003; -.
iPTMnet; P42574; -.
PhosphoSitePlus; P42574; -.
BioMuta; CASP3; -.
DMDM; 77416852; -.
OGP; P42574; -.
EPD; P42574; -.
MaxQB; P42574; -.
PaxDb; P42574; -.
PeptideAtlas; P42574; -.
PRIDE; P42574; -.
DNASU; 836; -.
Ensembl; ENST00000308394; ENSP00000311032; ENSG00000164305.
Ensembl; ENST00000523916; ENSP00000428929; ENSG00000164305.
GeneID; 836; -.
KEGG; hsa:836; -.
UCSC; uc003iwh.3; human.
CTD; 836; -.
DisGeNET; 836; -.
EuPathDB; HostDB:ENSG00000164305.17; -.
GeneCards; CASP3; -.
HGNC; HGNC:1504; CASP3.
HPA; CAB000091; -.
HPA; CAB008381; -.
HPA; HPA002643; -.
MIM; 600636; gene.
neXtProt; NX_P42574; -.
OpenTargets; ENSG00000164305; -.
PharmGKB; PA26087; -.
eggNOG; KOG3573; Eukaryota.
eggNOG; ENOG410ZQIE; LUCA.
GeneTree; ENSGT00760000118912; -.
HOGENOM; HOG000231878; -.
HOVERGEN; HBG050802; -.
InParanoid; P42574; -.
KO; K02187; -.
OMA; VDDDMAC; -.
OrthoDB; EOG091G05YD; -.
PhylomeDB; P42574; -.
TreeFam; TF102023; -.
BRENDA; 3.4.22.56; 2681.
Reactome; R-HSA-111459; Activation of caspases through apoptosome-mediated cleavage.
Reactome; R-HSA-111463; SMAC binds to IAPs.
Reactome; R-HSA-111464; SMAC-mediated dissociation of IAP:caspase complexes.
Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
Reactome; R-HSA-2028269; Signaling by Hippo.
Reactome; R-HSA-205025; NADE modulates death signalling.
Reactome; R-HSA-211227; Activation of DNA fragmentation factor.
Reactome; R-HSA-211736; Stimulation of the cell death response by PAK-2p34.
Reactome; R-HSA-264870; Caspase-mediated cleavage of cytoskeletal proteins.
Reactome; R-HSA-351906; Apoptotic cleavage of cell adhesion proteins.
Reactome; R-HSA-418889; Ligand-independent caspase activation via DCC.
Reactome; R-HSA-449836; Other interleukin signaling.
SABIO-RK; P42574; -.
SIGNOR; P42574; -.
EvolutionaryTrace; P42574; -.
GeneWiki; Caspase_3; -.
GenomeRNAi; 836; -.
PMAP-CutDB; P42574; -.
PRO; PR:P42574; -.
Proteomes; UP000005640; Chromosome 4.
Bgee; ENSG00000164305; -.
CleanEx; HS_CASP3; -.
ExpressionAtlas; P42574; baseline and differential.
Genevisible; P42574; HS.
GO; GO:0005829; C:cytosol; IDA:UniProtKB.
GO; GO:0031264; C:death-inducing signaling complex; IEA:Ensembl.
GO; GO:0045121; C:membrane raft; IEA:Ensembl.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:UniProtKB.
GO; GO:0005886; C:plasma membrane; TAS:Reactome.
GO; GO:0004190; F:aspartic-type endopeptidase activity; EXP:Reactome.
GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; IEA:Ensembl.
GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; TAS:Reactome.
GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
GO; GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; IMP:UniProtKB.
GO; GO:0005123; F:death receptor binding; IEA:Ensembl.
GO; GO:0008233; F:peptidase activity; IDA:UniProtKB.
GO; GO:0016005; F:phospholipase A2 activator activity; IEA:Ensembl.
GO; GO:0002020; F:protease binding; IEA:Ensembl.
GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome.
GO; GO:0008635; P:activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c; TAS:Reactome.
GO; GO:0006309; P:apoptotic DNA fragmentation; TAS:Reactome.
GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
GO; GO:0097190; P:apoptotic signaling pathway; TAS:BHF-UCL.
GO; GO:0001782; P:B cell homeostasis; IEA:Ensembl.
GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
GO; GO:0072734; P:cellular response to staurosporine; IMP:CAFA.
GO; GO:0030218; P:erythrocyte differentiation; IDA:UniProtKB.
GO; GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB.
GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; TAS:Reactome.
GO; GO:0034349; P:glial cell apoptotic process; IEA:Ensembl.
GO; GO:0007507; P:heart development; IEA:Ensembl.
GO; GO:0035329; P:hippo signaling; TAS:Reactome.
GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
GO; GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; IEA:Ensembl.
GO; GO:0030216; P:keratinocyte differentiation; IBA:GO_Central.
GO; GO:0007611; P:learning or memory; IEA:Ensembl.
GO; GO:0046007; P:negative regulation of activated T cell proliferation; IEA:Ensembl.
GO; GO:0043066; P:negative regulation of apoptotic process; IGI:MGI.
GO; GO:0030889; P:negative regulation of B cell proliferation; IEA:Ensembl.
GO; GO:0045736; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; IEA:Ensembl.
GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; IDA:MGI.
GO; GO:0030220; P:platelet formation; TAS:UniProtKB.
GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
GO; GO:0016485; P:protein processing; IEA:Ensembl.
GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
GO; GO:0016241; P:regulation of macroautophagy; TAS:ParkinsonsUK-UCL.
GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
GO; GO:0032025; P:response to cobalt ion; IEA:Ensembl.
GO; GO:0042493; P:response to drug; IEA:Ensembl.
GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
GO; GO:0009749; P:response to glucose; IEA:Ensembl.
GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
GO; GO:0034612; P:response to tumor necrosis factor; TAS:BHF-UCL.
GO; GO:0009411; P:response to UV; IEA:Ensembl.
GO; GO:0010165; P:response to X-ray; IEA:Ensembl.
GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
GO; GO:0043029; P:T cell homeostasis; IEA:Ensembl.
GO; GO:0042060; P:wound healing; IEA:Ensembl.
CDD; cd00032; CASc; 1.
InterPro; IPR029030; Caspase-like_dom_sf.
InterPro; IPR033139; Caspase_cys_AS.
InterPro; IPR016129; Caspase_his_AS.
InterPro; IPR002138; Pept_C14_p10.
InterPro; IPR001309; Pept_C14_p20.
InterPro; IPR015917; Pept_C14A.
PRINTS; PR00376; IL1BCENZYME.
SMART; SM00115; CASc; 1.
SUPFAM; SSF52129; SSF52129; 1.
PROSITE; PS01122; CASPASE_CYS; 1.
PROSITE; PS01121; CASPASE_HIS; 1.
PROSITE; PS50207; CASPASE_P10; 1.
PROSITE; PS50208; CASPASE_P20; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Apoptosis; Complete proteome; Cytoplasm;
Direct protein sequencing; Hydrolase; Phosphoprotein; Polymorphism;
Protease; Reference proteome; S-nitrosylation; Thiol protease;
Zymogen.
PROPEP 1 9
/FTId=PRO_0000004569.
PROPEP 10 28 {ECO:0000269|PubMed:7596430}.
/FTId=PRO_0000004570.
CHAIN 29 175 Caspase-3 subunit p17.
/FTId=PRO_0000004571.
CHAIN 176 277 Caspase-3 subunit p12.
/FTId=PRO_0000004572.
ACT_SITE 121 121 {ECO:0000250}.
ACT_SITE 163 163 {ECO:0000250}.
MOD_RES 1 1 N-acetylmethionine.
{ECO:0000244|PubMed:19413330,
ECO:0000244|PubMed:22223895}.
MOD_RES 11 11 N6-acetyllysine.
{ECO:0000250|UniProtKB:P70677}.
MOD_RES 26 26 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 163 163 S-nitrosocysteine; in inhibited form.
{ECO:0000269|PubMed:10213689}.
VARIANT 22 22 H -> R (in dbSNP:rs35578277).
/FTId=VAR_048616.
VARIANT 190 190 E -> D (in dbSNP:rs1049210).
{ECO:0000269|PubMed:15003516,
ECO:0000269|PubMed:7596430,
ECO:0000269|PubMed:7983002}.
/FTId=VAR_001401.
CONFLICT 31 36 ISLDNS -> MSWDTG (in Ref. 3; CAC88866).
{ECO:0000305}.
STRAND 41 51 {ECO:0000244|PDB:2DKO}.
HELIX 57 59 {ECO:0000244|PDB:2DKO}.
HELIX 67 80 {ECO:0000244|PDB:2DKO}.
STRAND 84 90 {ECO:0000244|PDB:2DKO}.
HELIX 93 105 {ECO:0000244|PDB:2DKO}.
HELIX 108 110 {ECO:0000244|PDB:1I3O}.
STRAND 111 120 {ECO:0000244|PDB:2DKO}.
STRAND 126 129 {ECO:0000244|PDB:2DKO}.
STRAND 132 135 {ECO:0000244|PDB:2DKO}.
HELIX 136 141 {ECO:0000244|PDB:2DKO}.
TURN 145 147 {ECO:0000244|PDB:2DKO}.
HELIX 149 151 {ECO:0000244|PDB:2DKO}.
STRAND 156 162 {ECO:0000244|PDB:2DKO}.
STRAND 165 167 {ECO:0000244|PDB:2DKO}.
STRAND 178 181 {ECO:0000244|PDB:2DKO}.
TURN 183 185 {ECO:0000244|PDB:1NMS}.
TURN 189 192 {ECO:0000244|PDB:2DKO}.
STRAND 193 199 {ECO:0000244|PDB:2DKO}.
STRAND 206 208 {ECO:0000244|PDB:2DKO}.
TURN 209 211 {ECO:0000244|PDB:2DKO}.
HELIX 214 226 {ECO:0000244|PDB:2DKO}.
TURN 227 229 {ECO:0000244|PDB:2DKO}.
HELIX 232 246 {ECO:0000244|PDB:2DKO}.
HELIX 254 256 {ECO:0000244|PDB:2DKO}.
STRAND 264 267 {ECO:0000244|PDB:2DKO}.
STRAND 270 272 {ECO:0000244|PDB:2DKO}.
SEQUENCE 277 AA; 31608 MW; 2F35CD3BCF7FF64A CRC64;
MENTENSVDS KSIKNLEPKI IHGSESMDSG ISLDNSYKMD YPEMGLCIII NNKNFHKSTG
MTSRSGTDVD AANLRETFRN LKYEVRNKND LTREEIVELM RDVSKEDHSK RSSFVCVLLS
HGEEGIIFGT NGPVDLKKIT NFFRGDRCRS LTGKPKLFII QACRGTELDC GIETDSGVDD
DMACHKIPVE ADFLYAYSTA PGYYSWRNSK DGSWFIQSLC AMLKQYADKL EFMHILTRVN
RKVATEFESF SFDATFHAKK QIPCIVSMLT KELYFYH


Related products :

Catalog number Product name Quantity
20-272-191566 Caspase 3 - Mouse monoclonal [3F49] to Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Monoclonal 0.25 ml
20-272-191563 Caspase 3 - Mouse monoclonal [4i29] to Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Monoclonal 0.05 mg
20-272-191564 Caspase 3 - Mouse monoclonal [3F48] to Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Monoclonal 0.25 ml
20-272-192342 Caspase 3 - Mouse monoclonal [3CSP03] to Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Monoclonal 0.5 ml
18-003-44327 Caspase-3 - EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Polyclonal 0.1 mg Protein A
U0626h CLIA Apopain,CASP3,CASP-3,Caspase-3,CPP32,CPP-32,Cysteine protease CPP32,Homo sapiens,Human,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
U0626r CLIA Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,IRP,LICE,Protein Yama,Rat,Rattus norvegicus,SCA-1,SREBP cleavage activity 1 96T
E0626m ELISA Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,LICE,Mouse,Mus musculus,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
E0626m ELISA kit Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,LICE,Mouse,Mus musculus,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
E0626r ELISA Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,IRP,LICE,Protein Yama,Rat,Rattus norvegicus,SCA-1,SREBP cleavage activity 1 96T
U0626m CLIA Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,LICE,Mouse,Mus musculus,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
E0626h ELISA Apopain,CASP3,CASP-3,Caspase-3,CPP32,CPP-32,Cysteine protease CPP32,Homo sapiens,Human,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
E0626r ELISA kit Apopain,Casp3,CASP-3,Caspase-3,Cpp32,CPP-32,Cysteine protease CPP32,IRP,LICE,Protein Yama,Rat,Rattus norvegicus,SCA-1,SREBP cleavage activity 1 96T
E0626h ELISA kit Apopain,CASP3,CASP-3,Caspase-3,CPP32,CPP-32,Cysteine protease CPP32,Homo sapiens,Human,Protein Yama,SCA-1,SREBP cleavage activity 1 96T
18-272-197059 active Caspase 3 - Rabbit polyclonal to active Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Polyclonal 0.05 mg
20-272-190901 active + pro Caspase 3 - Mouse monoclonal [31A1067] to active + pro Caspase 3; EC 3.4.22.56; CASP-3; Apopain; Cysteine protease CPP32; Yama protein; CPP-32; SREBP cleavage activity 1; SCA-1 Monoclonal 0.1 mg
OBT1274 Caspase_3 (CASP3), Apoptosis_Related Cysteine Protease, SCA_1, CPP32B,Yama, apopain, PARP Cleavage Protease, SREBP Cleavage Activity 1, ~40kD, Goat anti_Human; WB 100 µg.
E0626Rb ELISA kit Apopain,CASP3,CASP-3,Caspase-3,Cysteine protease CPP32,Oryctolagus cuniculus,Rabbit 96T
E0626Rb ELISA Apopain,CASP3,CASP-3,Caspase-3,Cysteine protease CPP32,Oryctolagus cuniculus,Rabbit 96T
U0626Rb CLIA Apopain,CASP3,CASP-3,Caspase-3,Cysteine protease CPP32,Oryctolagus cuniculus,Rabbit 96T
U1735m CLIA Casp11,CASP-11,Casp4,CASP-4,Caspase-11,Caspase-4,Caspl,Ich3,Mouse,Mus musculus,Protease ICH-3 96T
E1735m ELISA Casp11,CASP-11,Casp4,CASP-4,Caspase-11,Caspase-4,Caspl,Ich3,Mouse,Mus musculus,Protease ICH-3 96T
E1735m ELISA kit Casp11,CASP-11,Casp4,CASP-4,Caspase-11,Caspase-4,Caspl,Ich3,Mouse,Mus musculus,Protease ICH-3 96T
18-272-195092 Caspase 10 - Rabbit polyclonal to Caspase 10; EC 3.4.22.63; CASP-10; ICE-like apoptotic protease 4; Apoptotic protease Mch-4; FAS-associated death domain protein interleukin-1B-converting enzyme 2; FL 0.1 ml
18-272-197016 Caspase 10 - Rabbit polyclonal to Caspase 10; EC 3.4.22.63; CASP-10; ICE-like apoptotic protease 4; Apoptotic protease Mch-4; FAS-associated death domain protein interleukin-1B-converting enzyme 2; FL 0.1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur